Redeye provides its initial take on Genovis’ Q3 2022 report, which came in just below our expectations on sales but significantly above our EBIT estimate. The impact of the COVID-19 pandemic is easing, and Genovis saw growth in all geographic markets. We consider this a strong report from Genovis.